Persevere Therapeutics
perseveretherapeutics.com
Health Care
Oncology Therapeutics
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$1.6M
1 round on record
Latest round
$1.6M
Venture round · Feb 2026 · 8 mo ago
Team
51-200
employees, estimated range
The money's age
Fresh money
8 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2026 | $1.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Persevere Therapeutics Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Greg BoschExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.
KAHR Bio: Pioneering Immunotherapeutics for Advanced Cancer Treatment.
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
SirnaMed is committed to developing innovative therapies that directly target the cause of cancer development, progression and treatment…
Creating neoantigens by design… …to transform cancer treatments into cures. ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE…
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
People
Greg Bosch
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Chesterbrook
United States
HQ
50-200 est. staff
Financials
Total raised
$1.6M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $1.6M | Details |